Synlait Milk has gained regulatory approval to export lactoferrin to the United States to use in infant and toddler formula. By Sally Rae.
The Mid Canterbury milk processor is the second company to receive a generally recognised as safe (Gras) notice from the US Food and Drug Administration (FDA) to use lactoferrin in those applications.
A Gras notice was added to the FDA register once a food ingredient was scientifically proven to be safe for its intended use.
Lactoferrin is an iron-binding protein recognised for its antibacterial and anti-inflammatory properties. The process took more than six months to complete. In time, it might open up further opportunities for the company, managing director John Penno said.
Investment in a second wet-mix facility is under way to double the infant formula base powder capacity of the company’s Dunsandel site to 80,000 metric tonnes by November.